Renal Impairment Linked to Worse Prognosis in IgD Multiple Myeloma
TUESDAY, Dec. 20, 2022 (HealthDay News) -- For patients with immunoglobulin D multiple myeloma (IgD MM), those with renal impairment (RI) have poorer prognosis and shorter median survival than those with no renal impairment (no-RI), according to a study published online Nov. 23 in Frontiers in Oncology.
Ge Yan, from The First Affiliated Hospital of Zhengzhou University in China, and colleagues examined the risk factors of renal damage and prognosis in a study involving 85 patients with IgD MM. Patients were categorized into RI or no-RI groups (47 and 38 patients, respectively).
The researchers found that 55.3 percent of patients with IgD MM had renal damage as a complication, of which 59.6 percent presented with acute renal failure as the first manifestation. In IgD MM, serum β2-microglobulin was an independent risk factor for renal damage; however, a cytogenetic analysis suggested it had no effect on renal damage. No significant difference was seen in the effect of chemotherapy between the groups. In addition, no significant difference was seen in the proportion of patients with improved renal function after treatment for patients with acute renal failure in dialysis and no-dialysis groups. The median overall survival was significantly shorter in the RI versus the no-RI group (29 and >40 months, respectively).
"Patients with renal failure as the first manifestation should be screened as soon as possible to see whether it is related to MM," the authors write. "Additionally, for these patients, treatment of primary disease is more meaningful than dialysis."
Related Posts
Screening Newborns for ‘Bubble Boy’ Immune Disease Saves Lives
THURSDAY, June 22, 2023 (HealthDay News) -- Screening newborns for severe...
GLP-1 RA Use May Up Risk for Gallbladder, Biliary Diseases
THURSDAY, March 31, 2022 (HealthDay News) -- Use of glucagon-like peptide-1...
‘Spring Forward’: A Good Time to Check Batteries in Your Smoke Alarms
FRIDAY, March 10, 2023 (HealthDay News) -- When you turn your clock forward for...
Just 23% of U.S. Adults ‘Definitely’ Plan to Get New COVID Shot
WEDNESDAY, Sept. 27, 2023 (HealthDay News) -- Just 23% of American adults say...